| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 138, 373-384, Copyright © 1991 by American Society for Investigative Pathology
REGULAR ARTICLES |
C Joachim, D Games, J Morris, P Ward, D Frenkel and D Selkoe
Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA 02115.
A central unresolved issue in Alzheimer's disease is the origin of the extracellular amyloid beta protein (A beta P) found in senile plaques and its relationship to the dystrophic neurites that intimately surround it. Here the presence and distribution within senile plaques of various epitopes of the beta-amyloid precursor protein (APP) are compared with the distribution of A beta P itself and markers for plaque neurites. Several principal findings emerge: 1) antibodies to regions of APP outside of A beta P ('APP antibodies') recognize only a subgroup of senile plaques; 2) within these plaques, APP antibodies label discrete globular and granular structures morphologically resembling neurites; 3) virtually all of the plaques labeled by APP antibodies also contain neurites reactive with antibodies to tau; 4) double labeling with anti-tau and an APP antibody shows that the neuritelike profiles stained by the APP antibody are always closely associated with tau-positive neurites within the same plaque and that a minority of profiles appear to be labeled by both antibodies; and 5) antibodies to different regions throughout APP label the same profiles within plaques, suggesting the presence of the full-length precursor. The authors conclude that only a subgroup of senile plaques contain APP epitopes and that the immunostained structures are neurites. Because many A beta P-containing plaques in neocortex, cerebellum, and striatum were found to be devoid of any APP labeling, as were vascular A beta P deposits, it is unlikely that the extracellular A beta P is principally derived from the APP found within dystrophic neurites. The immunodetection of apparently full-length APP, an axonally transported protein, in selected plaque neurites provides yet another protein marker of neuritic dystrophy, possibly indicative of an aberrant regenerative response.
This article has been cited by other articles:
![]() |
H. Oakley, S. L. Cole, S. Logan, E. Maus, P. Shao, J. Craft, A. Guillozet-Bongaarts, M. Ohno, J. Disterhoft, L. Van Eldik, et al. Intraneuronal beta-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation J. Neurosci., October 4, 2006; 26(40): 10129 - 10140. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Szegedi, G. Juhasz, E. Rozsa, G. Juhasz-Vedres, Z. Datki, L. Fulop, Z. Bozso, A. Lakatos, I. Laczko, T. Farkas, et al. Endomorphin-2, an endogenous tetrapeptide, protects against A{beta}1-42 in vitro and in vivo FASEB J, June 1, 2006; 20(8): 1191 - 1193. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Lombardo, E. A. Stern, M. E. McLellan, S. T. Kajdasz, G. A. Hickey, B. J. Bacskai, and B. T. Hyman Amyloid-{beta} Antibody Treatment Leads to Rapid Normalization of Plaque-Induced Neuritic Alterations J. Neurosci., November 26, 2003; 23(34): 10879 - 10883. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Van Uden, M. Mallory, I. Veinbergs, M. Alford, E. Rockenstein, and E. Masliah Increased Extracellular Amyloid Deposition and Neurodegeneration in Human Amyloid Precursor Protein Transgenic Mice Deficient in Receptor-Associated Protein J. Neurosci., November 1, 2002; 22(21): 9298 - 9304. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Yang, D. Chandswangbhuvana, T. Shu, A. Henschen, and C. G. Glabe Intracellular Accumulation of Insoluble, Newly Synthesized Abeta n-42 in Amyloid Precursor Protein-transfected Cells That Have Been Treated with Abeta 1-42 J. Biol. Chem., July 16, 1999; 274(29): 20650 - 20656. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |